Boston Scientific
0.22 %
37.0 %
Yet to be announced
Company Overview
Boston Scientific Corporation is a global medical technology company that develops, manufactures, and markets medical devices used in various interventional medical specialties. The company's main products include devices used in cardiology, rhythm management, structural heart, endoscopy, urology, and pelvic health.
Their product portfolio includes stents, catheters, pacemakers, defibrillators, endoscopes, and various other medical devices used in minimally invasive procedures.
Revenue Sources
PassBased on Boston Scientific's SEC filings and product portfolio, their revenue comes from manufacturing and selling medical devices and equipment. These products and services are halal as they provide essential healthcare solutions and improve patient outcomes. No significant revenue is derived from haram sources.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Dec. 31, 2024 | $4.56b | $3.97b | - | $80.0m | 0.00% | 2.02% |
| Sept. 30, 2024 | $4.21b | $3.56b | - | $79.0m | 0.00% | 2.22% |
| June 30, 2024 | $4.12b | $3.68b | - | $77.0m | 0.00% | 2.09% |
| March 31, 2024 | $3.86b | $3.25b | - | $69.0m | 0.00% | 2.12% |
Analyzing the last four quarters: Interest expense to total expense ratios were consistently below 2.5%. The highest ratio was approximately 2.2% of total expenses, while interest income was negligible. The company's core operations, not interest-based activities, drive its business model.
Operational Ethics
PassBased on available information from SEC filings and company reports, there is no evidence of significant ongoing collaboration with the Chinese Communist Party. While the company has operations in China, these appear to be normal business operations without direct ties to the CCP. There is also no evidence of current material operations or R&D centers in Israel.
Comments